PrecisionOS has received FDA approval to market its virtual reality surgical planning tool.

PrecisionOS® has received a 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market InVisionOS™ a patient specific planning tool using Virtual Reality (VR). Surgeons can utilize an Oculus Quest 2 device to undertake preoperative planning with the patented software, which will be accessible in early 2022.

Read morePrecisionOS has received FDA approval to market its virtual reality surgical planning tool.

Become a Member